Long term retention and excretion of 201Tl in a patient after myocardial perfusion imaging
Autor: | C. Challeton-de Vathaire, D. Celier, S. Cassot, Eric Blanchardon, G. Herbelet, D. Franck, Jean-René Jourdain, J.-C. Martin, A. Biau, P. Boisson |
---|---|
Přispěvatelé: | Laboratoire d'évaluation de la dose interne (DRPH/SDI/LEDI), Institut de Radioprotection et de Sûreté Nucléaire (IRSN) |
Jazyk: | angličtina |
Rok vydání: | 2005 |
Předmět: |
radiation detector
Male urinalysis [SDV]Life Sciences [q-bio] tissue distribution Myocardial Ischemia Urine radiation detection Effective dose (radiation) 030218 nuclear medicine & medical imaging 0302 clinical medicine Urinary excretion heart function dose response Medicine Thallium gamma spectrometry Radiation Radiological and Ultrasound Technology medicine.diagnostic_test article General Medicine 3. Good health bioassay drug excretion 030220 oncology & carcinogenesis radioactivity radiation measurement Biological half-life radiation dose whole body counter thallium 201 heart muscle perfusion Urinalysis Metabolic Clearance Rate chemistry.chemical_element urinary excretion Excretion 03 medical and health sciences Myocardial perfusion imaging radioisotope distribution coronary artery bypass graft half life time Coronary Circulation case report follow up Humans Radiology Nuclear Medicine and imaging human Radionuclide Imaging Aged business.industry Public Health Environmental and Occupational Health Biological Transport Thallium Radioisotopes chemistry sodium iodide functional assessment heart scintiscanning Radiopharmaceuticals business Nuclear medicine |
Zdroj: | RADIATION PROTECTION DOSIMETRY RADIATION PROTECTION DOSIMETRY, 2005, 113 (1), pp.47-53. ⟨10.1093/rpd/nch430⟩ |
DOI: | 10.1093/rpd/nch430⟩ |
Popis: | 201Tl is widely used in nuclear medicine to carry out myocardial perfusion imaging (MPI). However, very limited data is available on long-term distribution in the body, excretion and corresponding dose. In this study we performed a 2 month follow-up of a patient who underwent MPI, by urine analysis and in vivo measurements. The biological half-life of thallium was consequently estimated to be 11.6-27 d, which is in partial agreement with previous studies. We also estimated excretion and retention of 200Tl, 201Tl and 202Tl isotopes using the biokinetic parameters from ICRP publication 53 and compared the forecast result with actual measurements. The latter demonstrated a higher urinary excretion and a higher body retention than what was expected. Our results therefore suggest that the long-term retention and consequently the effective dose coefficient for 201Tl considered in ICRP publications 53 and 80 may be slightly underestimated. © The Author 2005. Published by Oxford University Press. All rights reserved. |
Databáze: | OpenAIRE |
Externí odkaz: |